Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
June 18, 2021
Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles
Jason M Conley, Hongmao Sun, Kristin L Ayers, et al.
Journal of Chemical Information and Modeling
|
January 10, 2017
Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 Inhibitor
Neha Rana, Jason M Conley, Monica Soto-Velasquez, et al.
Bioorganic & Medicinal Chemistry
|
September 29, 2012
Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand
Alia H Clark, John D McCorvy, Jason M Conley, et al.
Islets
|
October 15, 2023
Dynamic regulation of pancreatic β cell function and gene expression by the SND1 coregulator <i>in vitro</i>
Sukrati Kanojia, Rebecca K Davidson, Jason M Conley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2014
Evaluation of AaDOP2 receptor antagonists reveals antidepressants and antipsychotics as novel lead molecules for control of the yellow fever mosquito, Aedes aegypti
Jason M Conley, Jason M Meyer, Andrew B Nuss, et al.
Nutrition & Diabetes
|
October 16, 2019
Gpr17 deficiency in POMC neurons ameliorates the metabolic derangements caused by long-term high-fat diet feeding
Austin M Reilly, Shudi Zhou, Sunil K Panigrahi, et al.
European Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity
Hu Zhu, Jason M Conley, Surendra Karavadhi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 7, 2013
Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor
Jason M Conley, Cameron S Brand, Amy S Bogard, et al.
Communications Biology
|
January 7, 2026
Distinct membrane binding properties of the two non-visual arrestins
Thomas D Killeen, Katelyn Tepper, Kyle W Miller, et al.
Cell Reports
|
January 5, 2022
Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion
Shijun Yan, Jason M Conley, Austin M Reilly, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
June 18, 2021
Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles
Jason M Conley, Hongmao Sun, Kristin L Ayers, et al.
Journal of Chemical Information and Modeling
|
January 10, 2017
Molecular Modeling Evaluation of the Enantiomers of a Novel Adenylyl Cyclase 2 Inhibitor
Neha Rana, Jason M Conley, Monica Soto-Velasquez, et al.
Bioorganic & Medicinal Chemistry
|
September 29, 2012
Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand
Alia H Clark, John D McCorvy, Jason M Conley, et al.
Islets
|
October 15, 2023
Dynamic regulation of pancreatic β cell function and gene expression by the SND1 coregulator <i>in vitro</i>
Sukrati Kanojia, Rebecca K Davidson, Jason M Conley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2014
Evaluation of AaDOP2 receptor antagonists reveals antidepressants and antipsychotics as novel lead molecules for control of the yellow fever mosquito, Aedes aegypti
Jason M Conley, Jason M Meyer, Andrew B Nuss, et al.
Nutrition & Diabetes
|
October 16, 2019
Gpr17 deficiency in POMC neurons ameliorates the metabolic derangements caused by long-term high-fat diet feeding
Austin M Reilly, Shudi Zhou, Sunil K Panigrahi, et al.
European Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity
Hu Zhu, Jason M Conley, Surendra Karavadhi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 7, 2013
Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor
Jason M Conley, Cameron S Brand, Amy S Bogard, et al.
Communications Biology
|
January 7, 2026
Distinct membrane binding properties of the two non-visual arrestins
Thomas D Killeen, Katelyn Tepper, Kyle W Miller, et al.
Cell Reports
|
January 5, 2022
Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion
Shijun Yan, Jason M Conley, Austin M Reilly, et al.
Page
of 3